But when appetite drops and you stop thinking about food, it becomes much harder to consistently meet nutrient and total energy needs, which directly influences things like: Nutrient status Training quality Recovery Hormone health Immune function Injury risk Race day readiness Additionally, while all forms of weight loss involves some degree of lean body mass loss, GLP-1 medications can exacerbate this issue if you're not careful about diet and strength training
V., Opaleye-Enakhimion, T., Udeogu, J
By identifying both the potential and the limitations of these delivery technologies, the article aims to inform future research directions in GLP-1-based therapeutics and improve treatment outcomes for patients with T2DM
In the new study, Lhteenvuo and his team looked at medical records from 228,000 people in Swedish who were diagnosed with alcohol use disorder from 2006 to 2023
Nine breast cancer patients were included, and the best response was seen in a 60-year-old woman, who had glucose levels of only 56105115 mg/dl after an oral glucose load
Genetic and physiological insights into satiation variability predict responses to obesity treatment
